Literature DB >> 15528620

Preventing and treating hepatitis B infection.

Rakesh Aggarwal1, Piyush Ranjan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15528620      PMCID： PMC526122          DOI： 10.1136/bmj.329.7474.1080

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  33 in total

1.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

Review 2.  Management of hepatitis B: 2000--summary of a workshop.

Authors:  A S Lok; E J Heathcote; J H Hoofnagle
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

Review 3.  EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).

Authors: 
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

Review 4.  Asian-Pacific consensus statement on the management of chronic hepatitis B: an update.

Authors:  Yun-Fan Liaw; Nancy Leung; Richard Guan; George K K Lau; Ismail Merican
Journal:  J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 4.029

5.  Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.

Authors:  N W Leung; C L Lai; T T Chang; R Guan; C M Lee; K Y Ng; S G Lim; P C Wu; J C Dent; S Edmundson; L D Condreay; R N Chien
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

6.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Patrick Marcellin; Ting-Tsung Chang; Seng Gee Lim; Myron J Tong; William Sievert; Mitchell L Shiffman; Lennox Jeffers; Zachary Goodman; Michael S Wulfsohn; Shelly Xiong; John Fry; Carol L Brosgart
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

7.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

Authors:  Stephanos J Hadziyannis; Nicolaos C Tassopoulos; E Jenny Heathcote; Ting-Tsung Chang; George Kitis; Mario Rizzetto; Patrick Marcellin; Seng Gee Lim; Zachary Goodman; Michael S Wulfsohn; Shelly Xiong; John Fry; Carol L Brosgart
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

8.  Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

Authors:  Rakesh Aggarwal; Uday C Ghoshal; Subhash R Naik
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083

9.  Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.

Authors:  Robert P Perrillo; Ching-Lung Lai; Yun-Fan Liaw; Jules L Dienstag; Eugene R Schiff; Solko W Schalm; E Jenny Heathcote; Nathaniel A Brown; Mark Atkins; Mary Woessner; Stephen D Gardner
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 10.  Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.

Authors:  Chloe L Thio
Journal:  Semin Liver Dis       Date:  2003-05       Impact factor: 6.115
View more
  15 in total

1.  Hepatitis B infections.

Authors:  Nicholas J Beeching
Journal:  BMJ       Date:  2004-11-06

2.  High risk groups are still not being vaccinated.

Authors:  Adam R Winstock
Journal:  BMJ       Date:  2005-01-22

3.  Interpreting hepatitis B serology.

Authors:  Ky Loh; St Kew
Journal:  Malays Fam Physician       Date:  2007-04-30

4.  Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention.

Authors:  Hueifang Chen; Shin-Ping Tu; Chong Z Teh; Mei-Po Yip; John H Choe; T Gregory Hislop; Victoria M Taylor; Beti Thompson
Journal:  J Community Health       Date:  2006-04

5.  Post exposure prophylaxis of HIV transmission after occupational injuries in Queen Elizabeth Central Hospital, Blantyre, Malawi, 2003 - 2008.

Authors:  Gerrit C van der Maaten; Mulinda Nyirenda; Micheal J Beadsworth; Alex Chitani; Theresa Allain; Joep J van Oosterhout
Journal:  Malawi Med J       Date:  2010-03       Impact factor: 0.875

Review 6.  Hepatitis B Infection: What The Primary Care Doctors Should Know.

Authors:  Loh Keng Yin; Kew Siang Tong
Journal:  Malays Fam Physician       Date:  2006-04-30

7.  Preventing and treating hepatitis B infection: immunisation is most important strategy to control hepatitis B.

Authors:  Osman David Mansoor; Nick Wilson
Journal:  BMJ       Date:  2005-01-22

8.  Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Authors:  Teerha Piratvisuth; George Lau; You-Chen Chao; Rui Jin; Anuchit Chutaputti; Q-B Zhang; Tawesak Tanwandee; Peter Button; Matei Popescu
Journal:  Hepatol Int       Date:  2008-02-05       Impact factor: 6.047

Review 9.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.

Authors:  Chuanfang Lee; Yan Gong; Jesper Brok; Elizabeth H Boxall; Christian Gluud
Journal:  BMJ       Date:  2006-01-27

10.  Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.

Authors:  Vijayakumar Velu; Subhadra Nandakumar; Saravanan Shanmugam; Suresh-Sakharam Jadhav; Prasad-Suryakant Kulkarni; Sadras-Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.